Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma - Institut Pasteur Access content directly
Journal Articles Blood Year : 2022

Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma

Isabelle Staropoli

Domains

Virology
Fichier principal
Vignette du fichier
bloodbld2021013714.pdf (581.78 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

pasteur-03696807 , version 1 (16-06-2022)

Licence

Copyright

Identifiers

Cite

Soledad Henriquez, Jérémie Zerbit, Timothée Bruel, Amani Ouedrani, Delphine Planas, et al.. Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma. Blood, 2022, 139 (6), pp.942-946. ⟨10.1182/blood.2021013714⟩. ⟨pasteur-03696807⟩
48 View
42 Download

Altmetric

Share

Gmail Facebook X LinkedIn More